Try our beta test site
1765 studies found for:    VEGF
Show Display Options
Rank Status Study
1 Completed Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Drug: VEGF Trap-Eye
2 Recruiting Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction
Condition: Foetal Growth Restriction
Interventions: Device: obstetric Ultrasound;   Other: serum Vascular Endothelial Growth Factor
3 Unknown  VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)
Condition: Extrahepatic Cholangiocarcinoma
Intervention: Procedure: surgical treatment
4 Not yet recruiting Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Other: CD 74, VEGF detection
5 Completed Serum VEGF as a Tubal Pregnancy Marker
Condition: Pregnancy, Ectopic
Intervention: Other: Dosage of VEGF serum concentration
6 Unknown  Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
Condition: Diabetic Macular Edema
Intervention:
7 Completed ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Condition: Exudative Age-related Macular Degeneration
Interventions: Drug: 24GyE proton and Anti-VEGF;   Drug: 16GyE and anti-VEGF;   Drug: Sham Irradiation and anti-VEGF
8 Completed Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)
Condition: Macular Edema
Intervention: Biological: VEGF Trap-Eye (BAY86-5321)
9 Unknown  Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
Condition: Wet AMD
Intervention:
10 Completed Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy
Condition: Complication Following Ectopic Pregnancy
Intervention:
11 Completed
Has Results
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD
Condition: Macular Degeneration
Intervention: Drug: VEGF Trap Eye
12 Completed Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
Condition: Neovascular Age Related Macular Degeneration
Interventions: Drug: VEGF Trap;   Biological: VEGF Trap
13 Withdrawn Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
Conditions: Glioma;   Meningioma
Intervention: Procedure: Blood test
14 Completed Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Condition: Macular Degeneration
Intervention: Drug: VEGF Trap
15 Withdrawn Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?
Conditions: Choroidal NeoVascularization;   Age-Related Macular Degeneration
Intervention: Genetic: VEGF genotyping
16 Completed VEGF Gene Transfer for Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Biological: VEGF
17 Terminated The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
Conditions: Macular Degeneration;   Regional Blood Flow;   Vascular Endothelial Growth Factor
Intervention: Drug: ranibizumab, bevacizumab or pegaptanib
18 Completed
Has Results
Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
Condition: Exudative Age-related Macular Degeneration.
Interventions: Dietary Supplement: Anti-VEGF plus AREDS-2;   Dietary Supplement: Anti-VEGF plus AREDS-1
19 Completed
Has Results
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Malignant Tumor of Peritoneum;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: docetaxel;   Biological: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Completed A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Condition: Idiopathic Polypoidal Choroidal Vasculopathy
Intervention: Drug: Zimura + Anti-VEGF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.